Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, T-Cell, Cutaneous

Explore clinical trials studying Lymphoma, T-Cell, Cutaneous. Study availability and eligibility vary by location and protocol.

54 public trials 12 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, T-Cell, Cutaneous trial results

Recruiting

ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome

NCT02848274

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations
  • City of Hope Duarte, California, United States
  • Stanford University, School of Medicine Palo Alto, California, United States
  • University of Iowa Iowa City, Iowa, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
View all 13 locations
View Trial Details
Recruiting

SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)

NCT07021495

Conditions
Abscess, Angioedema, Atopic Dermatitis (AD), +56 more
Locations
  • Radboud University Medical Center Nijmegen, Gelderland, Netherlands
  • Maastricht University Medical Center+ Maastricht, Limburg, Netherlands
  • Amsterdam University Medical Center Amsterdam, North Holland, Netherlands
  • University Medical Center Groningen Groningen, Provincie Groningen, Netherlands
View Trial Details
Active, not recruiting

Duvelisib and Nivolumab for the Treatment of Stage IIB-IVB Mycosis Fungoides and Sezary Syndrome

NCT04652960

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +13 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • UCHealth University of Colorado Hospital Aurora, Colorado, United States
  • UM Sylvester Comprehensive Cancer Center at Coral Gables Coral Gables, Florida, United States
  • UM Sylvester Comprehensive Cancer Center at Deerfield Beach Deerfield Beach, Florida, United States
View all 17 locations
View Trial Details
Active, not recruiting

Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency

NCT01787409

Conditions
Aggressive Non-Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +40 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Active, not recruiting

Pembrolizumab in Combination With Gemcitabine in People With Advanced Mycosis Fungoides or Sézary Syndrome

NCT04960618

Conditions
Advanced Mycosis Fungoides, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Active, not recruiting

Pembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas

NCT03598998

Conditions
Anaplastic Large Cell Lymphoma, Enteropathy-Associated T-Cell Lymphoma, Hemic and Lymphatic Diseases, +35 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
View Trial Details

Related conditions